Rodman & Renshaw 2015 Annual Global Investment Conference to be held in New York from September 8 to 10, 2015

Jul 09, 2015, 10:00 ET from Rodman & Renshaw Conferences, LLC

NEW YORK, July 9, 2015 /PRNewswire/ -- Rodman & Renshaw Conferences, LLC is hosting The Rodman & Renshaw Annual Global Investment Conference on September 8 through September 10, 2015 at the St. Regis Hotel in New York.  More than 200 public & private companies from around the world are expected to present to an audience of over 2,000 attendees.  The event will feature tracks devoted to Biotechnology/Healthcare, Metals & Mining, Technology, Cleantech and Growth.  The Conference will include corporate presentations and Q&A sessions, investor one-on-one meetings and daily networking opportunities.  Institutional investors, venture capitalists, private equity firms, sophisticated private investors and industry executives are welcome to attend this conference.  Register online at the Rodman & Renshaw Conference website at www.rodmanevents.com  or contact Lily Khaykina, Rodman & Renshaw's Conference Manager, at (212) 356-0529 or via e-mail at LK@rodmanevents.com

Presenting Companies (partial list)

22nd Century Group, Inc. (NYSE MKT: XXII)
Abeona Therapeutics, Inc. (NASDAQ: PTBI)
Accurexa Inc. (OTCQB: ACXA)
AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX)
Acme United Corporation (NYSE MKT: ACU)
Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM))
Active Power, Inc. (NASDAQ: ACPW)
ADMA Biologics, Inc. (NASDAQ: ADMA)
Aeterna Zentaris Inc. (NASDAQ: AEZS)
Aethlon Medical, Inc. (OTC BB: AEMD)
Agenus Inc. (NASDAQ: AGEN)
Alliqua BioMedical, Inc. (NASDAQ: ALQA)
Amarin Corporation plc (NASDAQ: AMRN)
American DG Energy Inc. (NYSE MKT: ADGE)
AmpliPhi Biosciences Corporation (OTCQB: APHB)
Apricus Biosciences, Inc. (NASDAQ: APRI)
Arch Therapeutics, Inc. (OTCQB: ARTH)
Arno Therapeutics, Inc. (OTC BB: ARNI)
Asterias Biotherapeutics, Inc. (NYSE MKT: AST)
Atossa Genetics Inc. (NASDAQ: ATOS)
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH)
Avino Silver & Gold Mines Ltd. (NYSE MKT: ASM)
Bacterin International (NYSE: BONE)
Bio Blast Pharma Ltd. (NASDAQ: ORPN)
Bio-Path Holdings, Inc. (NASDAQ: BPTH)
Biocept, Inc. (NASDAQ: BIOC)
BioLife Solutions, Inc. (NASDAQ: BLFS)
BioLineRx Ltd. (NASDAQ: BLRX)
Bionomics Ltd. (ASX & OTCQX respetively: BNO & BNOEF)
BioSpecifics Technologies Corp. (NASDAQ: BSTC)
Biota Pharmaceuticals, Inc. (NASDAQ: BOTA)
BioTime, Inc. (NYSE MKT: BTX)
Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI)
Capnia, Inc. (NASDAQ: CAPN)
Cardiome Pharma Corp. (NASDAQ: CRME)
CASI Pharmaceuticals, Inc. (NASDAQ: CASI)
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX)
Ceapro Inc. (TSX: CZO.V)
Celator Pharmaceuticals, Inc. (NASDAQ: CPXX)
Celsion Corporation (NASDAQ: CLSN)
Cesca Therapeutics Inc. (NASDAQ: KOOL)
Chembio Diagnostics, Inc. (NASDAQ: CEMI)
China Recycling Energy Corporation (NASDAQ: CREG)
Clean Diesel Technologies, Inc. (NASDAQ: CDTI)
Cleveland BioLabs, Inc. (NASDAQ: CBLI)
Codexis, Inc. (NASDAQ: CDXS)
CombiMatrix Corporation (NASDAQ: CBMX)
ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV)
CorMedix Inc. (NYSE MKT: CRMD)
Cortendo AB (OTC: CRTOF)
Critical Outcome Technologies Inc. (TSXV; OTCQB: COT.V; COTQF)
Curemark LLC
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC)
Cynapsus Therapeutics Inc. (TSX & OTCQX: CTH.TO & CYN)
Cynata Therapeutics Limited (ASX: CYP.AX)
CytoDyn Inc. (OTC BB: CYDY)
CytoSorbents Corporation (NASDAQ: CTSO)
CytRx Corporation (NASDAQ: CYTR)
DARA BioSciences, Inc. (NASDAQ: DARA)
Delcath Systems, Inc. (NASDAQ: DCTH)
DelMar Pharmaceuticals, Inc. (OTCQX: DMPI)
DiaMedica Inc. (OTCQB: DMCAF)
Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX)
Dot Hill Systems Corp. (NASDAQ: HILL)
DragonWave Inc. (NASDAQ: DRWI)
DURECT Corporation (NASDAQ: DRRX)
Echo Therapeutics, Inc. (NASDAQ: ECTE)
EDAP TMS S.A. (NASDAQ: EDAP)
Elite Pharmaceuticals, Inc. (OTCQB: ELTP)
eMagin Corporation (NYSE MKT: EMAN)
Emisphere Technologies, Inc. (OTC BB: EMIS)
Energy Fuels Inc. (TXX & NYSEMKT: EFR.TO)
Eyegate Pharmaceuticals, Inc. (OTC BB: EYEG)
Fate Therapeutics, Inc. (NASDAQ: FATE)
Finjan Holdings, Inc. (NASDAQ: FNJN)
Fission Uranium Corp. (TSX: FCU.TO)
Flex Pharma, Inc. (NASDAQ: FLKS)
FlexShopper, Inc. (OTCQB: FPAY)
Galectin Therapeutics Inc. (NASDAQ: GALT)
Galena Biopharma, Inc. (NASDAQ: GALE)
GenSpera Inc. (OTCQB: GNSZ)
Geodrill Limited (TSX: GEO.TO)
GeoVax Labs, Inc. (OTCQB: GOVX)
Global Blood Therapeutics
GoGold Resources Inc. (Toronto: GGD.TO)
Golden Minerals Company (NYSE MKT: AUMN)
Great Panther Silver Limited (NYSE MKT: GPR.TO)
Heat Biologics, Inc. (NASDAQ: HTBX)
Hecla Mining Company (NYSE: HL)
Immune Pharmaceuticals, Inc. (NASDAQ: IMNP)
Immunomedics, Inc. (NASDAQ: IMMU)
Imugene Limited (ASX: IMU.AX)
Information Services Group, Inc. (NASDAQ: III)
Inovio Pharmaceuticals, Inc. (NASDAQ: INO)
IntelGenx (OTC: IGXT)
International Stem Cell Corporation (OTCQB: ISCO)
Inuvo, Inc. (NYSE MKT: INUV)
Inventergy Global, Inc. (NASDAQ: INVT)
InVivo Therapeutics Holdings Corp. (OTC BB: NVIV)
Kadmon
Kaizen Discovery Inc. (TSX.V: KZD.V)
Kamada Ltd. (NASDAQ: KMDA)
La Jolla Pharmaceutical Company (NASDAQ: LJPC)
Liquidmetal Technologies, Inc. (OTC BB: LQMT)
MAG Silver Corp. (TSX: MAG.TO)
Magic Software Enterprises Ltd. (NASDAQ: MGIC)
Matinas BioPharma Holdings, Inc. (OTCQB: MTNB)
Mayne Pharma Group Limited (ASX: MYX.AX)
MDxHealth SA (OTC BB: MXDHF)
Merus Labs International Inc. (NASDAQ: MSLI)
MicroVision, Inc. (NASDAQ: MVIS)
Motif Bio plc (LSE: MTFB.L)
NanoViricides, Inc. (NYSE MKT: NNVC)
Neovacs S.A. (NYSE Alternext: ALNEV.PA)
NephroGenex, Inc. (NASDAQ: NRX)
NeuroMetrix, Inc. (NASDAQ: NURO)
NioCorp Developments, Ltd. (TSX: NB)
NovaBay Pharmaceuticals, Inc. (NYSE MKT: NBY)
Novatel Wireless Inc. (NASDAQ: NVTL)
Nuvo Research Inc. (TSX: NRI.TO)
Ocean Power Technologies, Inc. (NASDAQ: OPTT)
Oculus Innovative Sciences, Inc. (NASDAQ: OCLS)
Onconova Therapeutics, Inc. (NASDAQ: ONTX)
OncoSec Medical Incorporated (OTCQB: ONCS)
Oncothyreon Inc. (NASDAQ: ONTY)
Opexa Therapeutics, Inc. (NASDAQ: OPXA)
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP)
OXiGENE, Inc. (NASDAQ: OXGN)
Perseon Corporation (NASDAQ: PRSN)
Pershing Gold Corporation (OTCQB: PGLC)
Pixium Vision SA (Euronext Paris: PIX.PA)
PolyMet Mining Corp. (NYSE MKT: PLM)
Prescient Therapeutics Limited (ASX: VHL.AX)
Prima BioMed Ltd. (NASDAQ: PBMD)
Protalex, Inc. (OTC BB: PRTX)
Pure Bioscience, Inc. (OTCQB: PURE)
Radcom Ltd. (NASDAQ: RDCM)
RealNetworks Inc. (NASDAQ: RNWK)
RedHill Biopharma Ltd. (NASDAQ: RDHL)
RestorGenex Corporation (OTCQB: RESX)
Resverlogix Corp. (TSX: RVX.TO)
Rexahn Pharmaceuticals, Inc. (NYSE MKT: RNN)
Rock Creek Pharmaceuticals, Inc. (NASDAQ: RCPI)
Rosetta Genomics Ltd. (NASDAQ: ROSG)
Safeguard Scientifics, Inc. (NYSE: SFE)
Signal Genetics, Inc. (NASDAQ: SGNL)
SITO Mobile Ltd. (OTC BB: SITO)
Solar3D, Inc. (NASDAQ: SLTD)
Sorrento Therapeutics, Inc. (NASDAQ: SRNE)
Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI)
SteadyMed Ltd. (NASDAQ: STDY)
Stellar Biotechnologies, Inc. (OTCQB: SBOTF)
StemCells, Inc. (NASDAQ: STEM)
Stevia First Corp. (OTC BB: STVF)
Tecogen Inc. (NASDAQ: TGEN)
Threshold Pharmaceuticals, Inc. (NASDAQ: THLD)
Titan Pharmaceuticals, Inc. (OTCQB: TTNP)
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP)
Top Image Systems Ltd. (NASDAQ: TISA)
UQM Technologies, Inc. (NYSE MKT: UQM)
Ur-Energy Inc. (NYSE MKT: URG)
Uranium Energy Corp. (NYSE MKT: UEC)
VBI Vaccines Inc. (Nasdaq: VBIV)
Verastem, Inc. (NASDAQ: VSTM)
Vical Incorporated (NASDAQ: VICL)
Viggle Inc. (NASDAQ: VGGL)
Vista Gold Corp. (NYSE MKT: VGZ)
VolitionRX Limited (NYSE MKT: VNRX)
Vuzix Corporation (OTC BB: VUZI)
XTL Pharmaceuticals Ltd (Nasdaq: XTLB)

CONFERENCE SPONSORS

Marquee Sponsor

H.C. WAINWRIGHT & CO, LLC

Gold Sponsors

Blender; Marcum LLP

Silver Sponsors

Ellenoff Grossman & Schole LLP; Equities.com; Haynes and Boone, LLP; IRTH Communications; theIRapp®; Vintage

Bronze Sponsors

Bloomberg Brief; NASDAQ

 

 

SOURCE Rodman & Renshaw Conferences, LLC



RELATED LINKS

http://www.rodmanevents.com